May 2015 Newsletter 
Clinical Trial Working Groups
  • Open trial: Renal cell carcinoma (Illinois)
  • Next call: Wednesday, June 17 
    at 4 p.m. ET / 3 p.m. CT
  • Approved LOI: Esophageal (Indiana)
  • Next call: Friday, May 22 
    at 
    1 p.m. ET / 12 p.m. CT
  • Trial in start-up: Hepatocellular (Indiana)
  • Approved LOI: Esophageal (Indiana) 
  • Current concepts:
    • Colorectal (Wisconsin)
    • Rectal (Rutgers)
    • Pancreatic (Illinois)
  • Next call: Friday, May 8 
    at 3 p.m. ET / 2 p.m. CT
  • Current concepts:
    • First line triple negative metastatic breast cancer (Penn State)
    • ER+ and/or PR+ and HER2- breast cancer (Illinois)
    • Newly diagnosed ER+, HER2- breast cancer (Minnesota)
  • Next call: Tuesday, August 11 
    at 4 p.m. ET / 3 p.m. CT
    (June 10 call cancelled) 
  • Approved LOI: Endometrial carcinoma (Northwestern)
  • Next call: TBD after ASCO.
  • Current concept: Squamous cell carcinoma of the skin (Rutgers)
  • Next call: Thursday, July 30 
    at 1 p.m. ET / 12 p.m. CT
  • Next call: Wednesday, July 22 
    at 11 a.m. ET / 10 a.m. CT
    (May 27 call cancelled) 
  • Next call: Tuesday, August 11 
    at 1 p.m. ET / 12 p.m. CT
    (May 21 call cancelled) 
  • Next call: Tuesday, May 5 
    at 9 a.m. ET / 8 a.m. CT

Submit a Concept: Contact Jessica Roy at [email protected] or 317-634-5842, ext. 19

Join a CTWG: Contact Zoe Holt at  [email protected] or 317-634-5842, ext. 30.
Recent Milestones
April 2015: First participant enrolled in a BTCRC study.

March 2015: First BTCRC clinical trial opens at the University of Illinois.

November/December 2014: Launch of new clinical trial working groups in myeloid malignancies, lymphoid malignancies, multiple myeloma, melanoma/cutaneous oncology, and gynecologic malignancies. 

 

ASCO 2015 Meetings

The Big Ten Cancer Research Consortium will host meetings during ASCO 2015 in Chicago. All meetings listed below will take place at the Holiday Inn Chicago Mart Plaza River North, 350 West Mart Center Drive.

All meeting rooms are on the 14th Floor.

Drinks and appetizers will be provided.

  • Steering Committee and Cancer Center Directors:
    Friday, May 29, 7 - 8:30 p.m. CT in Western Stage Room.
  • Melanoma CTWG: Friday, May 29, 8:30 - 9:30 p.m. CT in Steamboat Hotel Room.
  • Breast CTWG: Saturday, May 30, 7 - 8 p.m. CT in Steamboat Hotel Room.
  • Gastrointestinal CTWG: Saturday, May 30, 7 - 8 p.m. CT in Merchants Hotel Room.
  • Genitourinary CTWG: Saturday, May 30, 8:30 - 9:30 p.m. CT in Merchants Hotel Room.
  • Hematologic Malignancies CTWGs: Sunday, May 31, 7 - 8 p.m. CT in Merchants Hotel Room.
  • Gynecologic CTWG: Sunday, May 31, 8:30 - 9:30 p.m. CT in Merchants Hotel Room.
For more information, contact Zoe Holt at [email protected], or call 317-634-5842, ext. 30.

Featured Member Profile
"The accomplishments of the last 20 years, more than any other period in cancer research, have set the stage for remarkably accelerated progress over the next 20 years, by teams that push the limits of what we imagined 'multidisciplinary' could mean."

-- Robert S. DiPaola, MD, director of Rutgers Cancer Institute of New Jersey, our
featured member for May.

Read more.


To see past member features, click here.
Teaming Up Against Skin Cancer

During National Melanoma/Skin Cancer Detection and Prevention Month, Big Ten Cancer Research Consortium member institutions are helping to raise awareness of skin cancers while advancing scientific knowledge through research that is making a difference in the lives of patients.

 

Carrie Best is one of those patients. Diagnosed with Merkel cell carcinoma, a rare cancer (about 2,000 cases were diagnosed in the U.S. in 2014), Best's cancer did not respond to initial treatment, and she was told her odds of recovery were less than one percent.

 

Read more to learn how Best's search for options led her to Howard Kaufman, MD, FACS, at the Rutgers Cancer Institute of New Jersey, and to a clinical trial where she experienced a dramatic turnaround.

 

A Rolling Party to Benefit Skin Cancer Research

Entering its third year, the Michigan State University College of Human Medicine Gran Fondo has quickly joined the ranks of top national rides. In January 2015, Gran Fondo Guide named it one of the "biggest and best" U.S. Gran Fondos. Already in its first two years, MSU's "Big Ride" has raised nearly $300,000 for skin cancer awareness, prevention, and research. Read more.

Spotlight on Melanoma

The University of Iowa Melanoma Multidisciplinary Oncology Group meets monthly to share and discuss melanoma-related projects at the University of Iowa. The group has provided funding to a number of researchers. Read more.


Want to know what's happening Across the Consortium?
Check out our latest edition here.
Q&A: Data Processes

In our latest Q&A, Big Ten Cancer Research Consortium (BTCRC) Administrative Headquarters addresses common questions related to data processes and capabilities. Questions include:

  • What electronic data capture system does Admin HQ use for clinical trials?
  • Does the EDC system allow for collection of biospecimens?
  • How are protocols developed in the EDC system?
  • How do sites gain access to the EDC system?
  • What is data validation?
  • How is data prepared for analysis?

Read more.